Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao Min

Showing results (401-410 of 416) with videos related to

Pageof 42
Sort By:
International Journal of Surgery (London, England)|February 6, 2024
Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II studyNing Li, Zhi Li, Qiang Fu, et al.
Molecular Biology Reports|November 25, 2010
IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controlsBin Xu, Xiao-Bing Niu, Zi-Dun Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Defining the role of syndecan-4 in mechanotransduction using surface-modification approachesRobert M Bellin, James D Kubicek, Matthew J Frigault, et al.
Membranes|February 25, 2023
Antimicrobial Peptide Mastoparan-AF Kills Multi-Antibiotic Resistant <i>Escherichia coli</i> O157:H7 via Multiple Membrane Disruption Patterns and Likely by Adopting 3-11 Amphipathic Helices to Favor Membrane InteractionChun-Hsien Lin, Ching-Lin Shyu, Zong-Yen Wu, et al.
Medicine|November 18, 2017
Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agentsChao-Min Huang, Tsung-Hui Hu, Kuo-Chin Chang, et al.
ACS Applied Materials & Interfaces|January 26, 2022
Magnetic Responsive Release of Nitric Oxide from an MOF-Derived Fe<sub>3</sub>O<sub>4</sub>@PLGA Microsphere for the Treatment of Bacteria-Infected Cutaneous WoundChieh-Wei Chung, Bo-Wen Liao, Shu-Wei Huang, et al.
Analytical Chemistry|April 20, 2023
Rapid <i>Escherichia coli</i> Cloned DNA Detection in Serum Using an Electrical Double Layer-Gated Field-Effect Transistor-Based DNA SensorAkhil K Paulose, Yueh-Ju Hou, Yu-Shan Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infectionKuo-Chin Chang, Po-Lin Tseng, Yi-Ying Wu, et al.
Plos One|August 11, 2017
Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis CChao-Min Huang, Kuo-Chin Chang, Chao-Hung Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2017
Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal studyYi-Hao Yen, Ming-Chao Tsai, Cheng-Kun Wu, et al.
Pageof 42

Showing results (401-410 of 416) with videos related to

Sort By:
Pageof 42
International Journal of Surgery (London, England)|February 6, 2024
Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II studyNing Li, Zhi Li, Qiang Fu, et al.
Molecular Biology Reports|November 25, 2010
IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controlsBin Xu, Xiao-Bing Niu, Zi-Dun Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Defining the role of syndecan-4 in mechanotransduction using surface-modification approachesRobert M Bellin, James D Kubicek, Matthew J Frigault, et al.
Membranes|February 25, 2023
Antimicrobial Peptide Mastoparan-AF Kills Multi-Antibiotic Resistant <i>Escherichia coli</i> O157:H7 via Multiple Membrane Disruption Patterns and Likely by Adopting 3-11 Amphipathic Helices to Favor Membrane InteractionChun-Hsien Lin, Ching-Lin Shyu, Zong-Yen Wu, et al.
Medicine|November 18, 2017
Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agentsChao-Min Huang, Tsung-Hui Hu, Kuo-Chin Chang, et al.
ACS Applied Materials & Interfaces|January 26, 2022
Magnetic Responsive Release of Nitric Oxide from an MOF-Derived Fe<sub>3</sub>O<sub>4</sub>@PLGA Microsphere for the Treatment of Bacteria-Infected Cutaneous WoundChieh-Wei Chung, Bo-Wen Liao, Shu-Wei Huang, et al.
Analytical Chemistry|April 20, 2023
Rapid <i>Escherichia coli</i> Cloned DNA Detection in Serum Using an Electrical Double Layer-Gated Field-Effect Transistor-Based DNA SensorAkhil K Paulose, Yueh-Ju Hou, Yu-Shan Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infectionKuo-Chin Chang, Po-Lin Tseng, Yi-Ying Wu, et al.
Plos One|August 11, 2017
Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis CChao-Min Huang, Kuo-Chin Chang, Chao-Hung Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2017
Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal studyYi-Hao Yen, Ming-Chao Tsai, Cheng-Kun Wu, et al.
Pageof 42